Astronaut and Pioneer Sally Ride Dies of Cancer

Sally Ride, one of the great pioneers of the NASA space program and the first American woman to go into orbit, has died from pancreatic cancer at her San Diego home. She was 61.

Ride first made history on 18 June 1983 at just 32 years old when she rode aboard the Space Shuttle Challenger. In the almost thirty years since her historic launch into space, a full 42 American women have followed in her footsteps.

In 1983 she became an instant hero to girls and women the world over, giving them, in the words of President Obama, "a powerful role model" who "inspired young girls to reach for the stars."

Remarkably, NASA only began allowing women to join the space program in 1978—about fifteen years after the Soviet space program became the first to put a woman into orbit. At that time, Ride was one of the initial six women who joined. Five years later she would find herself on the launch pad at the Kennedy Space Center on the cusp of history, with such feminist notables as Gloria Steinem present for the occasion.

Yet for Ride, that historic launch was not a great moment in feminism; it was another day at the office. Her professionalism and her devotion to science are what have contributed to her reputation while with NASA and they remain what will boost her legacy in the future.

Being an astronaut was only part of who Sally Ride was. She was a physicist and children's books author, she taught physics at the University of California at San Diego, and she ran her own company.

Sources: Various outlets

lymphoma roundup

More Articles

More Articles

In T cell lymphoma, T lymphocytes, which are an essential part of the body's immune response, become malignant. T cell lymphomas account for about...

Lymphomatoid Papulosis (LyP) is a rare skin disorder that involves cancerous looking skin lesions. It is more than a skin condition; it is the...

In non-Hodgkin's lymphoma, you have your B-cell lymphomas and you have your T-cell lymphomas.

Why B...

MALT lymphoma is a rare B-cell non-Hodgkin's lymphoma that typically runs an indolent or slow-growing clinical...

Mantle cell lymphoma (MCL) is a relatively rare B-cell subtype of non-Hodgkin'...

T-Cell Lymphoblastic Lymphoma (T-LBL) is a very rare subtype of non-Hodgkin's lymphoma. It tends to develop in...

In general, a diagnosis of T-cell lymphoma denotes a poorer prognosis than a diagnosis of B-cell lymphoma. One of...

Mantle cell lymphoma (MCL) is just one of 50-60 known B-cell subtypes of...

After some of the dust has settled, the thoughts of many new lymphoma patients turn to diet and nutrition. They want to know if, in the past,...

The term NK T cell lymphoma refers to one of two subtypes of lymphoma that affect the NK (Natural Killer)...

In a perfect world, every case of cancer would respond to, and be cured by first-line therapy. Unfortunately, it is not often the case. This is...

Prednisone is a glucocorticosteroid (a steroid) used in the treatment of many types of cancers. It functions as an anti-inflammatory medicine that...

In 1964, researchers at the National Cancer Institute developed the first combination chemotherapy that cured a...